A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Medical Science Liaison

Biology & BiotechConfirmed live in the last 24 hours
Full-time$187.7k - $253.9k

About the Job

Requirements

  • A PhD, Doctor of Pharmacy, Doctor of Nursing Practice, or Doctor of Medicine, with 3 to 5 years of industry experience.
  • A proven clinical background that enables scientifically meaningful engagement with health care professionals.
  • Experience in clinical research, patient recruitment, and investigator-sponsored trials.
  • Experience in medical education and key opinion leader management.
  • Ability to communicate evidence-based scientific information effectively.
  • Ability to work collaboratively and cross-functionally.
  • Ability to manage shifting priorities in a rapidly changing environment.
  • Decision-making and accountability.

Responsibilities

  • Partner closely with investigators and internal stakeholders to drive patient accrual.
  • Identify key opinion leaders and cultivate a network of experts for key Alnylam disease areas.
  • Develop, maintain, and execute U.S. key opinion leader and U.S. institution plans within the respective geography.
  • Conduct and implement a comprehensive disease awareness tactical plan within the respective geography.
  • Collaborate with health care professionals to identify opportunities to develop algorithms and guidelines that facilitate early diagnosis.
  • Provide in-depth drug mechanism-of-action and emerging clinical information to health care providers in the respective geography.
  • Serve as a liaison to health care professionals, professional organizations, disease-state advocacy groups, patient support groups, and educational foundations.
  • Provide medical and scientific input into the planning and execution of advisory boards, and work with experts to review speaker presentations and provide additional medical background when requested.
  • Contribute to Alnylam's achievement of company objectives for pre-approved products.
  • Provide educational meeting support at scientific congresses.
  • Coordinate required medical, legal, and regulatory review and approval of field documents for distribution or presentation.
  • Travel 60–70%.

Desired Qualifications

  • Prior experience in cardiology and rare disease is strongly preferred.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs